NASDAQ · PDEX
Healthcare · Medical - Instruments & Supplies
$71.85
Up+$4.94 (+7.38%)
Updated Sep 17, 2026, 10:38 AM
SID Score
6.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PDEX closed at $71.85 after 20 trading sessions, up 7.33% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $67.58 | $72.89 | $67.05 | $71.85 | 105.65K |
| Sep 15, 2026 | $66.03 | $68.30 | $65.95 | $66.91 | 70.65K |
| Sep 14, 2026 | $62.80 | $69.10 | $62.57 | $66.56 | 126.57K |
| Sep 11, 2026 | $59.84 | $63.565 | $59.39 | $62.805 | 63.04K |
| Sep 10, 2026 | $59.89 | $60.31 | $58.04 | $59.84 | 65.56K |
| Sep 9, 2026 | $65.65 | $66.40 | $58.45 | $60.70 | 153.68K |
| Sep 8, 2026 | $73.95 | $73.95 | $66.25 | $66.41 | 106.82K |
| Sep 4, 2026 | $69.54 | $77.00 | $69.54 | $73.41 | 150.24K |
| Sep 3, 2026 | $62.56 | $63.3123 | $60.20 | $61.75 | 64.74K |
| Sep 2, 2026 | $62.27 | $63.20 | $62.085 | $62.58 | 33.82K |
| Sep 1, 2026 | $61.90 | $63.195 | $59.92 | $61.40 | 92.08K |
| Aug 31, 2026 | $62.76 | $63.575 | $61.84 | $62.10 | 33.63K |
| Aug 28, 2026 | $64.89 | $64.89 | $62.17 | $62.555 | 56.66K |
| Aug 27, 2026 | $63.93 | $66.36 | $63.93 | $64.86 | 57.44K |
| Aug 26, 2026 | $65.61 | $65.61 | $63.41 | $63.84 | 79.33K |
| Aug 25, 2026 | $67.37 | $67.98 | $63.15 | $65.22 | 54.97K |
| Aug 24, 2026 | $65.30 | $67.32 | $65.30 | $66.86 | 25.65K |
| Aug 21, 2026 | $66.02 | $66.33 | $64.59 | $65.67 | 33.04K |
| Aug 20, 2026 | $66.28 | $67.38 | $65.84 | $66.31 | 35.84K |
| Aug 19, 2026 | $67.96 | $68.33 | $65.5001 | $66.94 | 41.85K |
The latest Smart Investors Daily articles mentioning PDEX.
PDEX research
Company profile and research snapshot.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | Ascendiant Capital | Buy | — |
| May 12, 2026 | Ascendiant Capital | Buy | — |
| May 27, 2025 | Ascendiant Capital | Buy | — |
| Nov 11, 2024 | Ascendiant Capital | Buy | — |
| Sep 9, 2024 | Ascendiant Capital | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 3, 2026
IRVINE, CA / ACCESS Newswire / September 3, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 fourth quarter and full-year ended June 30, 2026.
Benzinga · Sep 3, 2026
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.67 by 29.85 percent. This is a 141.67 percent increase over earnings of $0.36 per share from the same
Benzinga · Feb 12, 2026
PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition of Advanced Precision Machining LLC, ("APM"), formerly operated as Advanced Precision Machining, Inc., a manufacturing
Benzinga · Jan 29, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PDEX.
